-

MedsEngine Achieves High Blood Pressure Control In Less Than Two Office Visits

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine LLC, a provider of chronic disease management software, presented its findings on blood pressure control to the European Society of Hypertension in Milan, Italy, May 23-26, 2025. The findings showed that users of the MedsEngine Hypertension module were able to achieve high BP control rates, to a goal of <140/90, in less than two office visits.

"Hypertension control in less than 2 office visits for 10 consecutive years"

Share

These results build on earlier presentations at the European Society of Cardiology Congress in 2023 and 2024, where MedsEngine reported sustained blood pressure control rates of 92% over a 10-year period. Further analysis linked these outcomes to a significant reduction in heart attacks and cerebrovascular events, underscoring the long-term clinical impact of optimized hypertension management.

The MedsEngine platform enables physicians and advanced practice providers to rapidly evaluate patients and generate personalized, evidence-based medication recommendations in just minutes—transforming the standard of care for hypertension.

“Our data from over 14,000 patients across two major medical groups show that personalized, technology-driven medication recommendations dramatically reduce the risk of strokes and heart attacks and improve patient understanding and adherence,” said Dr. Doug Romer, Chief Medical Officer at MedsEngine. “This level of precision and efficiency illustrates the value of using technology to control chronic diseases.”

About MedsEngine

MedsEngine develops EHR-integrated clinical decision support applications that generate real-time, personalized, evidence-based medication recommendations for hypertension, cholesterol management, type 2 diabetes, and heart failure. Medical groups utilizing MedsEngine have seen nation-leading hypertension control, higher HEDIS scores and Star ratings, lower medical costs, standardized care across all providers, improved office workflow and greater patient understanding and satisfaction.

MedsEngine LLC


Release Versions

More News From MedsEngine LLC

MedsEngine Achieves SOC 2 Type II Certification: Reinforcing Our Commitment to Data Security

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine, a provider of chronic disease management software, is proud to announce that it has successfully attained SOC 2 Type II certification. This certification, awarded by the American Institute of Certified Public Accountants (AICPA), is a rigorous audit that evaluates a company's controls relevant to security, availability, processing integrity, confidentiality, and privacy. Dr. Doug Romer, CMO, stated, “this milestone underscores MedsEngine’s continued co...

MedsEngine Selected as Finalist in Payor Category of the Emerge Innovation Contest at HIMSS25

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine, a clinical decision support software designed to optimize treatment for hypertension, cholesterol, type 2 diabetes, and heart failure, is proud to announce they were selected as a finalist in the payor category of the Emerge Innovation Experience Contest at HIMSS25. Dr. Doug Romer, MedsEngine CMO, stated, “given the level of competition, having MedsEngine recognized among innovative solutions that are transforming healthcare delivery is truly an honor...

MedsEngine Announces Integration with AthenaOne EHR at Volunteers in Medicine

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine LLC is excited to announce its clinical decision support application is now integrated with AthenaOne EHR at the Volunteers in Medicine (VIM) Clinic in Hilton Head, SC. Dr. John Newman of VIM states, “partnering with MedsEngine allows our volunteer physicians, who come from a wide spectrum of medical backgrounds, to have greater confidence in their abilities to control chronic diseases in a primary care setting.” “Integrating our application with Athena...
Back to Newsroom